Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C23H36N4O5S3 |
| Molecular Weight | 544.751 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)CCCCC(CCSS\C(CCO)=C(\C)N(CC1=C(N)N=C(C)N=C1)C=O)SC(C)=O
InChI
InChIKey=VJTXQHYNRDGLON-PGMHBOJBSA-N
InChI=1S/C23H36N4O5S3/c1-16(27(15-29)14-19-13-25-17(2)26-23(19)24)21(9-11-28)35-33-12-10-20(34-18(3)30)7-5-6-8-22(31)32-4/h13,15,20,28H,5-12,14H2,1-4H3,(H2,24,25,26)/b21-16-
| Molecular Formula | C23H36N4O5S3 |
| Molecular Weight | 544.751 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 1 |
| Optical Activity | ( + / - ) |
DescriptionSources: http://drug-info.in/neuvita-octotiamine-fujisawa/
Sources: http://drug-info.in/neuvita-octotiamine-fujisawa/
Octotiamine is an analogue of vitamin B1. As a component of vitamin complex used for the treatment of vitamin B1 deficiency; vitamin B1 supplement.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://drug-info.in/neuvita-octotiamine-fujisawa/
Unknown
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:48:17 GMT 2025
by
admin
on
Mon Mar 31 18:48:17 GMT 2025
|
| Record UNII |
UN1Q7096GA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID3057640
Created by
admin on Mon Mar 31 18:48:17 GMT 2025 , Edited by admin on Mon Mar 31 18:48:17 GMT 2025
|
PRIMARY | |||
|
UN1Q7096GA
Created by
admin on Mon Mar 31 18:48:17 GMT 2025 , Edited by admin on Mon Mar 31 18:48:17 GMT 2025
|
PRIMARY | |||
|
C170239
Created by
admin on Mon Mar 31 18:48:17 GMT 2025 , Edited by admin on Mon Mar 31 18:48:17 GMT 2025
|
PRIMARY | |||
|
Octotiamine
Created by
admin on Mon Mar 31 18:48:17 GMT 2025 , Edited by admin on Mon Mar 31 18:48:17 GMT 2025
|
PRIMARY | |||
|
137-86-0
Created by
admin on Mon Mar 31 18:48:17 GMT 2025 , Edited by admin on Mon Mar 31 18:48:17 GMT 2025
|
PRIMARY | |||
|
5353843
Created by
admin on Mon Mar 31 18:48:17 GMT 2025 , Edited by admin on Mon Mar 31 18:48:17 GMT 2025
|
PRIMARY | |||
|
C002051
Created by
admin on Mon Mar 31 18:48:17 GMT 2025 , Edited by admin on Mon Mar 31 18:48:17 GMT 2025
|
PRIMARY | |||
|
m8119
Created by
admin on Mon Mar 31 18:48:17 GMT 2025 , Edited by admin on Mon Mar 31 18:48:17 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB09416MIG
Created by
admin on Mon Mar 31 18:48:17 GMT 2025 , Edited by admin on Mon Mar 31 18:48:17 GMT 2025
|
PRIMARY | |||
|
1979
Created by
admin on Mon Mar 31 18:48:17 GMT 2025 , Edited by admin on Mon Mar 31 18:48:17 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105140
Created by
admin on Mon Mar 31 18:48:17 GMT 2025 , Edited by admin on Mon Mar 31 18:48:17 GMT 2025
|
PRIMARY | |||
|
1470
Created by
admin on Mon Mar 31 18:48:17 GMT 2025 , Edited by admin on Mon Mar 31 18:48:17 GMT 2025
|
PRIMARY | |||
|
100000083308
Created by
admin on Mon Mar 31 18:48:17 GMT 2025 , Edited by admin on Mon Mar 31 18:48:17 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |